Martin Javier San, Chief Medical Officer at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 38,900 shares at $69.01 ($2.7M) on 2021-11-19, disclosed to the SEC on 2021-11-22.
Open-market sale of $2.7M ARWR by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $69.01 | 13,704 | $946K | 35.1% |
| 2 | $69.01 | 13,704 | $946K | 35.1% |
| 3 | $70.01 | 5,696 | $399K | 14.8% |
| 4 | $70.01 | 5,696 | $399K | 14.8% |
| 5 | $70.99 | 100 | $7K | 0.3% |
| Total | $69.31 avg | 38,900 |
| $2.7M |
| 100% |
| Filing → |
| ATHA | SELL | 2025-07-02 | $3K | — | Filing → |
| ATHA | SELL | 2025-01-03 | $6K | — | Filing → |
| ARWR | SELL | 2024-01-08 | $450K | — | Filing → |